Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis
Background For anemia management in patients with chronic kidney disease not on dialysis, darbepoetin alfa (DA), which has a shorter half-life but is more inexpensive than continuous erythropoietin receptor activator (CERA), is preferred in Korea. This study evaluated the efficacy, safety, and cost-...
Saved in:
Main Authors: | Geo Neul Park (Author), Kyung Ho Lee (Author), Ji Eun Moon (Author), Soo Jeong Choi (Author), Moo Yong Park (Author), Jin Kuk Kim (Author), Byung Chul Yu (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Once to Every Man
by: Evans, Larry, -1925; Fischer, Anton Otto, 1882-1962 [Illustrator] -
Once a week
by: Milne, A. A. (Alan Alexander), 1882-1956 -
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia
by: Leslie Citrome, et al.
Published: (2024) -
The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004) -
Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
by: Inaishi J, et al.
Published: (2022)